For First Time, Morris Animal Foundation Names Veterinarian As Executive Director

The 44-year-old Morris Animal Foundation is one of the few granting agencies in the United States to which researchers investigating animal medicine can turn for funding support. The group's new executive director, Robert Hilsenroth, says he hopes that under his leadership, the foundation not only will make significant gains in public awareness, but also will increase the size of its endowment. Hilsenroth, a veterinarian in Denver who sold his private practice 2 1/2 months ago, says he is th

Written byRon Kaufman
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hilsenroth, a veterinarian in Denver who sold his private practice 2 1/2 months ago, says he is the first licensed veterinarian to become a full-time staff member of the Englewood, Colo., foundation. This year, he says, the 62 studies currently under way received just under $1 million in foundation funding. The foundation awards the vast majority of its grants to studies in medical research affecting dogs, cats, horses, and some zoo animals (Judy Henderson, The Scientist, July 20, 1992, page 22).

Hilsenroth says competition for Morris Foundation grants is stiff. "Right now we get between 250 and 300 proposals a year, and we're only able to fund about 20 to 25 of them," he says. Most of the funded studies are conducted in 27 U.S. and four Canadian veterinary hospitals.

"It's a shame. There are quite a few grants that become approved for funding, but we don't have the money," ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies